Evidence map›Paper›PMID 32843371›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2020

Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care: Perspectives of Patients and Providers on ESAS-r:Renal.

Jenna M Evans, Alysha Glazer, Rebecca Lum, Esti Heale, Marnie MacKinnon, Peter G Blake, Michael Walsh

Abstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Effect of online hemodiafiltration on quality of life, fatigue and recovery time: a systematic review and meta-analysis.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Pooled it
  3. Perceived benefits and limitations of using patient-reported outcome measures in clinical practice with individual patients: a systematic review of qualitative studies.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022
    Pooled it
  4. Pooled it
  5. Mapping the Edmonton Symptom Assessment System-Revised: Renal to the EQ-5D-5L in patients with chronic kidney disease.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022
    Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Validation of Patient-Reported Outcome Measure in Pediatric CKD (PRO-Kid).Clinical journal of the American Society of Nephrology : CJASN · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jenna M EvansDeGroote School of Business, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0003-3104-9889
Alysha GlazerOntario Renal Network, Ontario Health, Toronto, Ontario, Canada.
Rebecca LumOntario Renal Network, Ontario Health, Toronto, Ontario, Canada.
Esti HealeOntario Renal Network, Ontario Health, Toronto, Ontario, Canada.
Marnie MacKinnonOntario Renal Network, Ontario Health, Toronto, Ontario, Canada.
Peter G BlakeOntario Renal Network, Ontario Health, Toronto, Ontario, Canada.
Michael WalshOntario Renal Network, Ontario Health, Toronto, Ontario, Canada.ORCID 0000-0001-8292-2014

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe Edmonton Symptom Assessment System Revised: Renal is a patient-reported outcome measure used to assess physical and psychosocial symptom burden in patients treated with maintenance dialysis. Studies of patient-reported outcome measures suggest the need for deeper understanding of how to optimize their implementation and use. This study examines patient and provider perspectives of the implementation process and the influence of the Edmonton Symptom Assessment System Revised: Renal on symptom management, patient-provider communication, and interdisciplinary communication. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Eight in-facility hemodialysis programs in Ontario, Canada, assessed patients using the Edmonton Symptom Assessment System Revised: Renal every 4-6 weeks for 1 year. Screening and completion rates were tracked, and pre- and postimplementation surveys and midimplementation interviews were conducted with patients and providers. A chart audit was conducted 12 months postimplementation.

resultsIn total, 1459 patients completed the Edmonton Symptom Assessment System Revised: Renal; 58% of eligible patients completed the preimplementation survey (

conclusionsThe Edmonton Symptom Assessment System Revised: Renal patient-reported outcome measure may be useful to standardize symptom screening, enhance awareness of psychosocial symptoms among patients and providers, and empower patients rather than to reduce symptom burden.

Indexed as

Patient Reported Outcome MeasuresRenal DialysisSymptom AssessmentAgedAttitude of Health PersonnelFemaleHealth Knowledge, Attitudes, PracticeHealth StatusHumansKidney DiseasesLongitudinal StudiesMaleMental HealthOntarioPatient ParticipationTime Factorschronic kidney diseaseend stage kidney diseasenephrologypatient-reported outcomesrenalsymptom managementsymptom screening

Identifiers

PMID32843371
PMCPMC7480546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.